Beyond glycemic control: differential effects of empagliflozin and sitagliptin on insulin sensitivity and a shared increase in adropin in type 2 diabetes. - Taha OS; Azami G; Saed L; Hakhamaneshi MS; Moridi H (BMC endocrine disorders, 2026)